SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001060426-10-000001
Filing Date
2010-01-20
Accepted
2010-01-20 11:49:37
Documents
1
Period of Report
2009-10-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5916
  Complete submission text file 0001060426-10-000001.txt   7935
Mailing Address 15 EXCHANGE PLACE, SUITE 500 JERSEY CITY NJ 07302
Business Address 15 EXCHANGE PLACE, SUITE 500 JERSEY CITY NJ 07302 646-367-1747
CHINA AOXING PHARMACEUTICAL COMPANY, INC. (Issuer) CIK: 0001060426 (see all company filings)

IRS No.: 650636168 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O WESTMINSTER SECURITIES CORP 100 WALL ST, 7TH FLOOR NEW YORK NY 10005
Business Address
OSHEA JOHN P (Reporting) CIK: 0001139589 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32674 | Film No.: 10535295